PostoperAtive Neurocognitive Dysfunction After Major Abdominal Surgery (PANDS) (PANDS)

May 1, 2024 updated by: Xiangcai Ruan, MD, PhD, Sixth Affiliated Hospital, Sun Yat-sen University

Postoperative Neurocognitive Dysfunction After Major Abdominal Surgery: A Prospective Observational Cohort Study

Predisposing and precipitating factors for perioperative delirium for the elderly remain elusive. This research will be conducted to determine risk factors of postoperative delirium.

Study Overview

Status

Recruiting

Detailed Description

This study intends to include 500 participants over 65 years old undergoing elective abdominal major surgery. The primary outcome is incidence of delirium at 7 days postoperatively, and the secondary outcomes include preoperative sleep disorders(Athens In-somnia Scale, AIS), postoperative cognitive impairment (Abbreviated Mental Test Score, AMTS), postoperative pain (NRS pain score), incidence of significant postoperative complications, length of hospital stay, and serum biomarkers levels.

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510100
        • Recruiting
        • The Sixth Affiliated Hospital of Sun Yet-set University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients aged 65 to 90 years who received elective major abdominal surgery (estimated operation time over 2 hours)

Description

Inclusion Criteria:

  1. 65 to 90 years old to receive elective major abdominal surgery (expected operation time over 2 hours); ,
  2. American society of Aneshesiologists(ASA)physical status I-III;

Exclusion Criteria:

  1. Mini-Mental State Examination (MMES) score < 15;
  2. Renal failure (requiring dialysis) or liver failure (Child-Pugh score > 5);
  3. Severe impairment due to structural or hypoxic brain injury, more than 2 days in ICU one month before surgery;
  4. Underwent major heart, lung or abdominal surgery within 1 year;
  5. Positive for Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or symptomatic (e.g. fever, cough, loss of taste/smell);
  6. The cognitive assessment cannot be completed because the subject is blind, deaf, or unable to communicate in the local language;
  7. Long-term follow-up unavailable (homelessness, active psychosis or substance abuse).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Prospective observational cohorts
patients undergoing elective major abdominal surgery (estimated operation time over 2 hours)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of delirium during first 7 days after surgery
Time Frame: Consecutive 7 days after the surgery or hospital discharge, whichever comes first.
The result of 3-minute Diagnostic Interview for Confusion Assessment Method (3D-CAM) is positive.
Consecutive 7 days after the surgery or hospital discharge, whichever comes first.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preoperative cognitive function
Time Frame: Day 1 before surgery
The Mini-Mental State Examination scale will be used to assist in evaluating preoperative cognitive function in patients. The scale's testing items include orientation, memory, calculation, language, visual space, use, and attention, with a total score of 30. The higher the score, the better the cognitive function, and the score below 27 indicates possible cognitive impairment.
Day 1 before surgery
Age-adjusted Charlson Comorbidity Index
Time Frame: Day 1 before surgery
Age-adjusted Charlson Comorbidity Index is a method used to evaluate the impact of multiple diseases on a patient's health status. The scale includes a total of 16 common co-morbidity diseases, which is divided into 4 categories according to different disease severity, with scores of 1,2,3 or 6. The higher the score, the more kinds of diseases the patient suffers at the same time, and their health status may be more complex and fragile.
Day 1 before surgery
Preoperative anxiety
Time Frame: Day 1 before surgery, day 3 after surgery
Hamilton Anxiety Scale will be used to evaluate the patient's anxiety status, which consist of 14 items. All items are scored on a 5-level scale of 0-4, with criteria for each level being none, mild, moderate, severe, and extremely severe. The higher the score, the more severe the anxiety symptoms.
Day 1 before surgery, day 3 after surgery
Serum biomakers levels
Time Frame: Within 15 minutes after induction of anesthesia, day 3 after surgery
Extract venous blood samples from the target patient, store and centrifuge the Samples appropriately. Quantitatively detect the serum biomakers levels, such as NFL, using enzyme-linked immunosorbent assay, and retest the concentration changes of these biomarkers 3 days after surgery.
Within 15 minutes after induction of anesthesia, day 3 after surgery
Preoperative Sleep quality
Time Frame: Day 1 before surgery, Day 3 after surgery
Athens Insomnia Scale will be used to assess the patient's preoperative sleep quality. A maximum total score of 24 indicates the most severe symptoms of insomnia, while a cut-off point of ≥6 represents a minimum criterion for the confirmation of insomnia symptoms.
Day 1 before surgery, Day 3 after surgery
Postoperative pain
Time Frame: Consecutive 7 days after the surgery or hospital discharge, whichever comes first.
Postoperative pain will be evaluated by Number Rating Scale, which is composed of 11 numbers from 0 to 10, where 0 is no pain or hurt and 10 is the most or worst pain. The higher the number, the more severe the pain.
Consecutive 7 days after the surgery or hospital discharge, whichever comes first.
Length of hospital stay
Time Frame: Up to 24 weeks after surgery
The length of patient hospital stay will be supplemented through Hospital Information System after surgery.
Up to 24 weeks after surgery
Health status and quality of life
Time Frame: Day 1 before surgery, day 30 after surgery
Short Form 36 Health Survey will be used to estimate the health status and quality of life of patients. This scale includes 8 dimensions and a total of 36 questions, convert the scores of each section into a range of 0 to 100, where 100 represents the "best health state", and the lower the score, the worse the health condition.
Day 1 before surgery, day 30 after surgery
Postoperative adverse complications
Time Frame: Up to day 30 after surgery
Include but limited to hospital readmissions 30 days after surgery, unplaned reoperations, stroke, kidney failure, and wound infections.
Up to day 30 after surgery
All-cause mortality at 30 days after surgery
Time Frame: Up to day 30 after surgery
The ratio of total deaths from all causes to the population.
Up to day 30 after surgery
Postoperative cognitive dysfunction
Time Frame: Day 1 before surgery, day 30 after surgery, day 90 after surgery
The Abbreviated Mental Test Score will be administered by telephone respectively 1 month and 3 months after surgery to identify long-term cognitive consequences of anaesthesia and postoperative delirium. The scale consists of 10 questions with a total of 10 points, the higher the score, the better the cognitive function, and those with score < 8 will be identified as possible neurocognitive dysfunction.
Day 1 before surgery, day 30 after surgery, day 90 after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xiangcai Ruan, MD, PhD, Sixth Affiliated Hospital, Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 11, 2023

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

December 2, 2023

First Submitted That Met QC Criteria

December 21, 2023

First Posted (Actual)

December 26, 2023

Study Record Updates

Last Update Posted (Actual)

May 3, 2024

Last Update Submitted That Met QC Criteria

May 1, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-143-v2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elective Major Abdominal Surgery

3
Subscribe